$250 | Single User
$500 | Site License
$750 | Global License

GlaxoSmithKline Plc (GSK) - Medical Equipment - Deals and Alliances Profile [Report Updated: 16-10-2018]

Published by Global Data: 16 Oct 2018 | 225389 | In Stock

Introduction

Summary

GlaxoSmithKline Plc (GSK) is a healthcare company, which focuses on the development, manufacture and commercialization of pharmaceuticals, vaccines and consumer healthcare products. It offers drugs for the treatment of HIV, respiratory, cancer, immuno-inflammation, anti-virals, central nervous system (CNS), metabolic, cardiovascular and urogenital, anti-bacterials, dermatology and rare diseases. The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and gastro-intestinal diseases. GSK’s vaccine portfolio cover various diseases including hepatitis, diphtheria, tetanus, whooping cough, rotavirus and HPV infections, measles and bacterial meningitis, among others. The company sells its products through wholesalers, pharmacies, hospitals, physicians and other groups worldwide. GSK is headquartered in Brentford, Middlesex, the UK.

GlaxoSmithKline Plc (GSK) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents
for GlaxoSmithKline Plc (GSK) - Medical Equipment - Deals and Alliances Profile [Report Updated: 16-10-2018]

  • Table of Contents

    Table of Contents 3

    List of Tables 6

    List of Figures 7

    GlaxoSmithKline Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 8

    GlaxoSmithKline Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 9

    GlaxoSmithKline Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 10

    GlaxoSmithKline Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 11

    GlaxoSmithKline Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 12

    GlaxoSmithKline Plc, Medical Equipment, Deal Details 17

    Venture Financing 17

    23andMe to Raise up to USD300 Million in Financing 17

    Reciprocal Labs (Propeller Health) Secures USD20 Million in Venture Funding 18

    NeuSpera Medical Raises USD26 Million in Series B Financing Round 20

    SetPoint Medical Raises USD30 Million in Series D Financing 21

    Saluda Medical Raises USD39.4 Million in Series D Financing 23

    Progyny Raises Additional USD10 Million in Series B Financing 24

    ZappRx Secures USD25 Million in Series B Funding 25

    SetPoint Medical Raises Funds through Venture Financing 26

    Propeller Health Raises USD21.5 Million in Series C Financing 28

    CVRx Raises USD57.7 Million in Series G Financing 29

    Cala Health Raises USD18 Million in Series A Financing Round 31

    Setpoint Medical Raises Additional USD15 Million in Series C Venture Financing 33

    Avhana Health Raises USD0.7 Million in Seed Financing 35

    Progyny Raises Additional Funds through Venture Financing 36

    ZappRx Raises USD5.6 Million in Series A Financing 37

    HTG Molecular Diagnostics Raises Funds Through Extended Series E Financing 38

    ZappRx Raises US Million In Seed Financing 39

    Setpoint Medical Raises US Million In Venture Financing 40

    Health XL Raises Funds Through Venture Financing 41

    HTG Molecular Diagnostics Raises US.5 Million In Series E Financing 42

    SR One Plans To Invest In Biotechnology Company 43

    IlluminOss Medical Raises US Million In Series C Financing 44

    Auxogyn Raises US Million In Series B Financing 46

    Partnerships 48

    Covance Enters into Strategic Technology Agreement with GlaxoSmithKline 48

    NeuroMetrix to Enter into Agreement with GlaxoSmithkline Consumer Healthcare 49

    Owlstone Medical Enters into Co-Development Agreement with GlaxoSmithKline 50

    EnteroMedics Enters into Agreement with Galvani Bioelectronics 51

    GlaxoSmithKline to Form Joint Venture with Verily Life Sciences 52

    GlaxoSmithKline May Form Joint Venture with Qualcomm 53

    Propeller Health Expands Agreement with GlaxoSmithKline 54

    Thermo Fisher Scientific Enters into Co-Development Agreement with GlaxoSmithKline and Pfizer 55

    Cepheid Enters into Co-Development Agreement with AstraZeneca, Cubist Pharma and GSK 56

    Feinstein Institute For Medical Research Enters Into Research Agreement With GSK, University of Pennsylvania And MIT 57

    AB-Biotics Enters Into Co-Promotion Agreement With GlaxoSmithKline For Neurofarmagen 59

    KineMed Enters Into Co-Development Agreement With GlaxoSmithKline 60

    Epistem Holdings Enters Into Co-Development Agreement With GlaxoSmithKline 61

    Siemens Healthcare Diagnostics Enters Into Co-Development Agreement With ViiV Healthcare 62

    Ionis Pharmaceuticals Enters Into Licensing Agreement with Glaxo Group and GlaxoSmithKline 63

    Equity Offering 64

    Response Genetics Completes Private Placement Of Shares For US Million 64

    Debt Offering 65

    GlaxoSmithKline Raises USD1.19 Billion in Public Offering of 1.25% Bonds Due 2026 65

    GlaxoSmithKline Raises USD897.1 Million in Public Offering of Bonds Due 2020 66

    GlaxoSmithKline Raises USD897.1 Million in Public Offering of 1.75% Bonds Due 2030 67

    GlaxoSmithKline Raises USD1.25 Billion in Public Offering of 3.375% Bonds Due 2023 68

    GlaxoSmithKline Raises USD0.75 Billion in Public Offering of Bonds Due 2021 69

    GlaxoSmithKline Raises USD1.75 Billion in Public Offering of 3.875% Bonds Due 2028 70

    GlaxoSmithKline Raises USD1.25 Billion in Public Offering of 3.125% Bonds Due 2021 71

    GlaxoSmithKline Raises USD1 Billion in Public Offering of 3.625% Bonds Due 2025 72

    GlaxoSmithKline Raises USD832.8 Million in Public Offering of Bonds Due 2026 73

    GlaxoSmithKline Raises USD1,428 Million in Public Offering of Bonds Due 2020 74

    Asset Transactions 75

    Sinclair IS Pharma Acquires Atlean From Stiefel Labs 75

    Acquisition 76

    GlaxoSmithKline Acquires Remaining 36.5% Stake in GlaxoSmithKline Consumer Healthcare from Novartis for USD13 Billion 76

    GlaxoSmithKline May Acquire Vectura for USD1.62 Billion 78

    Teleflex Acquires Semprus BioSciences For Up To USD80 Million 79

    GlaxoSmithKline Plc - Key Competitors 81

    GlaxoSmithKline Plc - Key Employees 82

    GlaxoSmithKline Plc - Locations And Subsidiaries 83

    Head Office 83

    Other Locations & Subsidiaries 83

    Joint Venture 96

    Recent Developments 98

    Strategy And Business Planning 98

    Oct 30, 2017: GSK opens new regional headquarters for Asia in Singapore 98

    Feb 16, 2017: GSK and EMBL have signed an agreement to enhance understanding of disease and drug mechanisms 99

    Financial Announcements 100

    Jul 25, 2018: GSK delivers improvements in sales, margins and cash flow in Q2 2018 100

    Feb 07, 2018: GSK delivers improvements in sales, margins and cash flow in 2017 103

    Oct 25, 2017: GSK delivers Q3 sales of £7.8 billion, +4% AER, +2% CER 104

    Jul 26, 2017: GSK delivers further progress in Q2 and sets out new priorities for the Group 116

    Apr 26, 2017: GSK delivers another quarter of continued progress 122

    Feb 08, 2017: GlaxoSmithKline: Results announcement for the fourth quarter 2016 125

    Corporate Communications 141

    Aug 07, 2018: Iain Mackay appointed GSK Chief Financial Officer 141

    Jul 12, 2018: James Ford appointed GSK General Counsel 142

    Jun 12, 2018: GSK announces changes to Vaccines and Global Manufacturing & Supply leadership 143

    May 09, 2018: Simon Dingemans, Chief Financial Officer, to retire from GSK 144

    Apr 18, 2018: GlaxoSmithKline Names Kevin Sin as new Senior Vice President and Head of Worldwide Business Development for Research & Development 145

    Jan 09, 2018: Representative Director and President of GlaxoSmithKline Corporation Personnel notice 146

    Nov 08, 2017: Patrick Vallance, President, R&D, GSK to become UK Government's Chief Scientific Adviser 147

    Nov 08, 2017: Dr Hal Barron appointed Chief Scientific Officer and President, Research & Development, GSK 148

    Jul 25, 2017: Karenann Terrell appointed Chief Digital & Technology Officer, GSK 149

    Jul 21, 2017: GSK announces Board and Committee changes 150

    Jun 19, 2017: GSK confirms start date for Luke Miels 151

    Apr 04, 2017: GSK responds to Cyclone Debbie 152

    Jan 20, 2017: Luke Miels will succeed Abbas Hussain as President, Global Pharmaceuticals, GSK 153

    Jan 19, 2017: Abbas Hussain to leave GSK 154

    Jan 19, 2017: Luke Miels appointed President, Global Pharmaceuticals, GSK 155

    Legal and Regulatory 156

    Feb 23, 2018: GSK, Ministry of Economy, Trade and Industry "Superior Health and Good Management Act 2018 (White 500)" for 2 consecutive years certified 156

    Product News 157

    Sep 13, 2018: IN(3D)USTRY to gather the latest 3D-printing medical applications 157

    Jul 09, 2018: Microsoft and Partners Showcase a New 'Molecule' for Better Health Outcomes 158

    Feb 05, 2018: Amiko receives CE mark for three novel inhaler sensors 159

    Other Significant Developments 160

    Oct 24, 2017: COPD Foundation, Geisinger, GSK, and Jvion Team Together to Help COPD Patients 160

    Aug 30, 2017: GSK responds to UK Life Sciences Industrial Strategy 161

    Appendix 162

    Methodology 162

    About GlobalData 162

    Contact Us 162

    Disclaimer 162

List Of Tables
in GlaxoSmithKline Plc (GSK) - Medical Equipment - Deals and Alliances Profile [Report Updated: 16-10-2018]

List of Tables

GlaxoSmithKline Plc, Medical Equipment, Key Facts, 2017 2

GlaxoSmithKline Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

GlaxoSmithKline Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 8

GlaxoSmithKline Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 9

GlaxoSmithKline Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 10

GlaxoSmithKline Plc, Deals By Market, 2012 to YTD 2018 11

GlaxoSmithKline Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 12

23andMe to Raise up to USD300 Million in Financing 17

Reciprocal Labs (Propeller Health) Secures USD20 Million in Venture Funding 18

NeuSpera Medical Raises USD26 Million in Series B Financing Round 20

SetPoint Medical Raises USD30 Million in Series D Financing 21

Saluda Medical Raises USD39.4 Million in Series D Financing 23

Progyny Raises Additional USD10 Million in Series B Financing 24

ZappRx Secures USD25 Million in Series B Funding 25

SetPoint Medical Raises Funds through Venture Financing 26

Propeller Health Raises USD21.5 Million in Series C Financing 28

CVRx Raises USD57.7 Million in Series G Financing 29

Cala Health Raises USD18 Million in Series A Financing Round 31

Setpoint Medical Raises Additional USD15 Million in Series C Venture Financing 33

Avhana Health Raises USD0.7 Million in Seed Financing 35

Progyny Raises Additional Funds through Venture Financing 36

ZappRx Raises USD5.6 Million in Series A Financing 37

HTG Molecular Diagnostics Raises Funds Through Extended Series E Financing 38

ZappRx Raises US Million In Seed Financing 39

Setpoint Medical Raises US Million In Venture Financing 40

Health XL Raises Funds Through Venture Financing 41

HTG Molecular Diagnostics Raises US.5 Million In Series E Financing 42

SR One Plans To Invest In Biotechnology Company 43

IlluminOss Medical Raises US Million In Series C Financing 44

Auxogyn Raises US Million In Series B Financing 46

Covance Enters into Strategic Technology Agreement with GlaxoSmithKline 48

NeuroMetrix to Enter into Agreement with GlaxoSmithkline Consumer Healthcare 49

Owlstone Medical Enters into Co-Development Agreement with GlaxoSmithKline 50

EnteroMedics Enters into Agreement with Galvani Bioelectronics 51

GlaxoSmithKline to Form Joint Venture with Verily Life Sciences 52

GlaxoSmithKline May Form Joint Venture with Qualcomm 53

Propeller Health Expands Agreement with GlaxoSmithKline 54

Thermo Fisher Scientific Enters into Co-Development Agreement with GlaxoSmithKline and Pfizer 55

Cepheid Enters into Co-Development Agreement with AstraZeneca, Cubist Pharma and GSK 56

Feinstein Institute For Medical Research Enters Into Research Agreement With GSK, University of Pennsylvania And MIT 57

AB-Biotics Enters Into Co-Promotion Agreement With GlaxoSmithKline For Neurofarmagen 59

KineMed Enters Into Co-Development Agreement With GlaxoSmithKline 60

Epistem Holdings Enters Into Co-Development Agreement With GlaxoSmithKline 61

Siemens Healthcare Diagnostics Enters Into Co-Development Agreement With ViiV Healthcare 62

Ionis Pharmaceuticals Enters Into Licensing Agreement with Glaxo Group and GlaxoSmithKline 63

Response Genetics Completes Private Placement Of Shares For US Million 64

GlaxoSmithKline Raises USD1.19 Billion in Public Offering of 1.25% Bonds Due 2026 65

GlaxoSmithKline Raises USD897.1 Million in Public Offering of Bonds Due 2020 66

GlaxoSmithKline Raises USD897.1 Million in Public Offering of 1.75% Bonds Due 2030 67

GlaxoSmithKline Raises USD1.25 Billion in Public Offering of 3.375% Bonds Due 2023 68

GlaxoSmithKline Raises USD0.75 Billion in Public Offering of Bonds Due 2021 69

GlaxoSmithKline Raises USD1.75 Billion in Public Offering of 3.875% Bonds Due 2028 70

GlaxoSmithKline Raises USD1.25 Billion in Public Offering of 3.125% Bonds Due 2021 71

GlaxoSmithKline Raises USD1 Billion in Public Offering of 3.625% Bonds Due 2025 72

GlaxoSmithKline Raises USD832.8 Million in Public Offering of Bonds Due 2026 73

GlaxoSmithKline Raises USD1,428 Million in Public Offering of Bonds Due 2020 74

Sinclair IS Pharma Acquires Atlean From Stiefel Labs 75

GlaxoSmithKline Acquires Remaining 36.5% Stake in GlaxoSmithKline Consumer Healthcare from Novartis for USD13 Billion 76

GlaxoSmithKline May Acquire Vectura for USD1.62 Billion 78

Teleflex Acquires Semprus BioSciences For Up To USD80 Million 79

GlaxoSmithKline Plc, Key Competitors 81

GlaxoSmithKline Plc, Key Employees 82

GlaxoSmithKline Plc, Other Locations 83

GlaxoSmithKline Plc, Subsidiaries 84

GlaxoSmithKline Plc, Joint Venture 96

List Of Figures, Charts and Diagrams
in GlaxoSmithKline Plc (GSK) - Medical Equipment - Deals and Alliances Profile [Report Updated: 16-10-2018]

List of Figures

GlaxoSmithKline Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

GlaxoSmithKline Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

GlaxoSmithKline Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

GlaxoSmithKline Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

GlaxoSmithKline Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 8

GlaxoSmithKline Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 9

GlaxoSmithKline Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 10

GlaxoSmithKline Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 11

Additional Details

Publisher

Global Data

Publisher Information

Reference

225389 | GDME4279D

Number of Pages

162

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
GlaxoSmithKline Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info
GlaxoSmithKline K.K. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryGlaxoSmithKline K.K. (GSK Japan) a subsidiary of GlaxoSmithKline Plc is a pharmaceutical comp...
10 Mar 2016 by Global Data USD $250 More Info
GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryGlaxoSmithKline Pharmaceuticals Limited (GSK India) is a pharmaceutical company that manufact...
04 Mar 2016 by Global Data USD $250 More Info
GlaxoSmithKline Plc (GSK) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryGlaxoSmithKline plc (GSK) is a healthcare company, which focuses on the development, manufact...
04 Mar 2016 by Global Data USD $250 More Info
GlaxoSmithKline Plc (GSK) - Medical Equipment - Deals and Alliances Profile
SummaryGlaxoSmithKline plc (GSK) is a healthcare company, which focuses on the development, manufact...
24 Feb 2016 by Global Data USD $250 More Info
GlaxoSmithKline Consumer Nigeria PLC (GLAXOSMITH) - Financial and Strategic SWOT Analysis Review
SummaryGlaxoSmithKline Consumer Nigeria PLC (GlaxoSmithKline Consumer Nigeria) a subsidiary of Glaxo...
09 Jan 2016 by Global Data USD $300 More Info
GlaxoSmithKline Consumer Nigeria PLC (GLAXOSMITH) - Financial and Strategic SWOT Analysis Review
SummaryGlaxoSmithKline Consumer Nigeria PLC (GlaxoSmithKline Consumer Nigeria) a subsidiary of Glaxo...
08 Nov 2015 by Global Data USD $300 More Info
Physician Views: Is GlaxoSmithKline's BRAF/MEK combo making headway in V600 mutation-positive melanoma patients?
Scope Although the clinical promise of cancer immunotherapies looks poised to see these products gai...
22 Jul 2014 by FirstWord Pharma USD $695 More Info
Physician Views: Assessing the launch of GlaxoSmithKline's Breo Ellipta
Scope It remains early in the launch, but available evidence suggests that GlaxoSmithKline's Breo El...
21 Jan 2014 by FirstWord Pharma USD $695 More Info
Physician Views: Can GlaxoSmithKline strike early with Anoro? / What role will dosing, inhaler type play in uptake of LAMA/LABA combinations for COPD?
ScopeThis year looks set to be one of notable evolution for the US chronic obstructive pulmonary dis...
01 Aug 2013 by FirstWord Pharma USD $695 More Info

This report is published by Global Data

Download Free Report Summary PDF

GlaxoSmithKline Plc (GSK) - Medical Equipment - Deals and Alliances Profile [Report Updated: 16-10-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data